Transforming mental wellbeing through scientific innovation
A shadow pandemic of mental health disorders
The WHO estimate that 1 in 8 people globally live with a mental health condition. These conditions include depression, substance use disorder and post-traumatic stress disorder.
We do not accept the status quo.
We envision a world where this burden is lifted.
We seek to enhance mental well-being.
Pacalis: Latin. Adjective.
Of or pertaining to peace, peaceful.
Pacalis Therapeutics Pty Ltd is a privately-held biotechnology company focused on the optimization and development of next-generation medicines for key classes of mental health disorders.
Innovating new therapeutics to improve mental health
Harnessing its co-founders' expertise across pharmacology, neuroscience and drug discovery and development, Pacalis is developing first-in-class therapeutics for conditions such as Major Depressive Disorder (MDD), Substance Use Disorder (SUD) and Post-Traumatic Stress Disorder (PTSD).
The Experienced Team Driving Pacalis
-
Warwick Tong
Director
-
David Bibby
CEO & Co-Founder
-
Chris Langmead
CSO & Co-Founder
-
Arthur Christopoulos
Co-Founder